Sunday, 2 April, 2023

Topic: Vaccine

India vaccine against cervical cancer to be launched Thursday, ‘will combat global shortage’

The Serum Institute of India & Department of Biotechnology are set to launch the country's first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer.

After Covid, mRNA vaccine for cancer? US researchers report initial success against melanoma

Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.

How ICAR grew 50 generations of virus over 1.5 years to develop lumpy skin disease vaccine

Lumpi-ProVac, a vaccine developed by 2 Indian Council of Agricultural Research institutes, was found effective in preventing lumpy skin disease in cattle & is ready for commercial launch.

Covaxin safe for kids, generates higher antibody response in them than adults, says Lancet paper

The results of the phase ⅔ clinical trials of the indigenous Covid vaccine have been peer-reviewed and published in the The Lancet Infectious Diseases journal.

Celebrities can’t use ‘my body, my choice’ to oppose Covid vaccine. They aren’t special

Morality is not limited to just not causing harm. For better or worse, many people look up to celebrities as people to admire and emulate.

Modi, Rahul Gandhi, and Djokovic — what liberals miss

The Djokovic episode is a real-life dilemma of moral philosophy that will be cited as a case study for future philosophy courses.

Omicron shows why global vaccine chains should be ready for unforeseen shocks

As Covid pandemic moves to epidemic conditions with regional hotspots, caution must be taken because any fault line in global vaccine supply can be cataclysmic.

India makes progress in child vaccination against diarrhoea, pneumonia amid Covid, report says

According to the IVAC report, India’s coverage of pneumococcal conjugate vaccine, increased by 6 percentage points while rotavirus vaccine for diarrhoea, rose by 29 percentage points.

Covid travel can be an opportunity, not just a risk

There are emotional and economic costs to restricting travel. No relaxation of curbs is risk-free, but it has to be balanced against the progress made in managing Covid.

Bharat Biotech’s Ankleshwar plant, manufacturer of rabies vaccine, rolls out 1st batch of Covaxin

Health Minister Mansukh Mandaviya released the first commercial batch of Covaxin from the Gujarat plant Sunday, said it had the capacity to produce more than 1 crore doses per month.

On Camera


File photo of smog in Delhi. Some doctors have called air pollution a bigger threat than Covid-19.| Photo: Suraj Singh Bisht | ThePrint

Air quality is better but not enough to banish air purifiers. Here are options for your room & car

What’s the solution for people who cannot leave Delhi? Air purifiers from Dyson's expensive range to Xiaomi's affordable ones can be of help.

NFRA to conduct audit quality inspections of five audit firms

New Delhi, Nov 16 (PTI) The National Financial Reporting Authority (NFRA) will carry out audit quality inspections of five audit firms, including the...


The Defence Services Staff College in Wellington | Image credit:

In a first, six women officers to enter prestigious Defence Services Staff College

As many as 15 women appeared for the examination, out of which six were selected, including one who has made it to the course along with her husband. 

Why military is more for asserting political will, not just about controlling territory

No matter what tactics, doctrine, or weapon system is used, the objective of any war is to control territory, argues Gen. MM Naravane (retd). But it's politics that matters most.